Oct

20

2025

Hamlet Biopharma bjuder in till digitalt investerarmöte den 31 oktober 12.00 2025

Hamlet Biopharma

|

Press releases

Hamlet Biopharma bjuder in till digitalt investerarmöte den 31 oktober 12.00 Klicka på länken nedan för att delta. Det går bra att ställa frågor till ...

Read more

Oct

01

2025

Hamlet BioPharma presenterade vid Financial Stockholm-evenemanget den 29 september 2025

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att företaget presenterade de sena...

Read more

Sep

23

2025

Monthly investor meeting on the 25th of September

Hamlet Biopharma

|

Press releases

Hamlet BioPharma invites you to our September investors’ meeting to be held on the 25th of September 2025, at 12:00. Please click on the link below to...

Read more

Sep

22

2025

Hamlet BioPharma prepares for next steps and secures drug manufacturing of Alpha1H at Phase III quality

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, ticker Hamlet, the pharmaceutical company specializing in the development of drugs for cancer and infections, today announces the su...

Read more

Sep

12

2025

Riktad emission registrerad på Bolagsverket

Hamlet Biopharma

|

Press releases

Den 18 juli 2025 offentliggjorde styrelsen i Hamlet BioPharma AB AB (publ) beslut om en riktad emission av units bestående av aktier och teckningsopti...

Read more

Sep

09

2025

Hamlet BioPharma secures new patents to develop scientific discoveries into drugs for the treatment of cancer and infections

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, a global leader in the treatment of cancer and infections announces the successful granting of new patents, strengthening its intell...

Read more

Sep

04

2025

Doctoral thesis to be defended today: Title ‘’Tumor response mechanisms and treatment effects of alpha1-oleate’’

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the PhD thesis defense by ...

Read more

Aug

28

2025

Year-end Report (Q4) July 2024 – June 2025

Hamlet Biopharma

|

Financial, Press releases

    ...

Read more

Aug

27

2025

Hamlet BioPharma bjuder in till pressträff torsdag 28 augusti

Hamlet Biopharma

|

Press releases

Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdag 28 augusti, 2025, klockan 12.00....

Read more

Aug

21

2025

Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the completion of the succ...

Read more

Aug

11

2025

Extra bolagsstämma beslutade att godkänna styrelsens förslag om riktad nyemission för att finansiera fortsatt utveckling och kommersialisering baserad på tre positiva Fas II studier

Hamlet Biopharma

|

Press releases

Lund, 11 augusti 2025, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar idag att extra...

Read more

Jul

24

2025

Hamlet BioPharma bjuder in till pressträff den 25 juli

Hamlet Biopharma

|

Press releases

Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff fredagen den 25 juli, 2025, klockan 11.3...

Read more

Jul

24

2025

Kallelse till extra bolagsstämma i Hamlet BioPharma AB (publ) – 11 augusti 2025

Hamlet Biopharma

|

Press releases

Aktieägarna i Hamlet BioPharma AB (publ) (”Hamlet BioPharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma 11 augusti 20...

Read more

Jul

18

2025

Hamlet BioPharma proposes a directed new share issue to finance continued development and commercialization based on three positive Phase II studies

Hamlet Biopharma

|

Press releases

Lund, 18 July 2025, Hamlet BioPharma, an innovative pharmaceutical company that develops new therapies against cancer and infections, announces today ...

Read more

Jul

18

2025

Hamlet BioPharma föreslår riktad nyemission för att finansiera fortsatt utveckling och kommersialisering baserat på tre positiva Fas II studier

Hamlet Biopharma

|

Press releases

Lund, 18 juli 2025, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar idag att bolaget ...

Read more

Jun

25

2025

Hamlet BioPharma Holds Successful In Person Meeting with US FDA

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announces the successful first...

Read more

Jun

17

2025

Hamlet BioPharma announces progress in Tuberculosis therapy

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, today announces progress in Tubercul...

Read more

Jun

17

2025

Hamlet BioPharma invites to investor meeting on the 18th of June

Hamlet Biopharma

|

Press releases

As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 18th of June 2025, at 12:00. Please click on ...

Read more

May

22

2025

Q3 Interim Report January – March 2025

Hamlet Biopharma

|

Financial, Press releases

    ...

Read more

May

21

2025

Hamlet BioPharma bjuder in till pressträff den 22 maj

Hamlet Biopharma

|

Press releases

Med anledning av bolagets kvartalsrapport 3 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 22 maj, 2025, ...

Read more

May

19

2025

Vetenskapligt genombrott för Alpha1H:s verkningsmekanism i blåscancer

Hamlet Biopharma

|

Press releases

Som tidigare rapporterats har Hamlet BioPharma uppnått banbrytande forskningsresultat om Alpha1H, bolagets läkemedelskandidat mot urinblåsecancer. I s...

Read more

May

19

2025

Scientific Breakthrough in Alpha1H’s Mechanism of Action

Hamlet Biopharma

|

Press releases

As previously reported, Hamlet BioPharma has achieved a groundbreaking scientific discovery related to Alpha1H, the company’s lead drug candidate for t...

Read more

May

02

2025

Hamlet BioPharma presenterar framgångsrika prekliniska och kliniska data för Alpha1H vid AACR 2025 – stärker positionen inom behandling av blåscancer

Hamlet Biopharma

|

Press releases

Hamlet BioPharma utvald att presentera framgångsrika prekliniska och kliniska data för Alpha1H vid AACR 2025 vid American Association for Cancer Resea...

Read more

Apr

22

2025

Hamlet BioPharma invites to investor meeting on the 23rd of April

Hamlet Biopharma

|

Press releases

As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 23rd of April 2025, at 12:00. Please click on...

Read more

Apr

08

2025

New discoveries in infection biology, highlighting the rich potential of non-antibiotic treatments of infections

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the publication of new sci...

Read more

Apr

08

2025

New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the publication of new sci...

Read more

Apr

07

2025

New granted patents added to Hamlet BioPharma’s extensive patent portfolio in cancer and infection

Hamlet Biopharma

|

Press releases

Hamlet BioPharma’s extensive patent portfolio comprises 147 granted patents and 33 pending cases. Strategy regarding intellectual property right...

Read more

Apr

07

2025

Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA.

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces that Hamlet BioPharma’s dr...

Read more

Mar

12

2025

Hamlet BioPharma bjuder in till investerarmöte den 12 mars

Hamlet Biopharma

|

Press releases

Som tidigare meddelats bjuder Hamlet BioPharma in till månatligt investerarmöte onsdagen den 12 mars, 2025, klockan 12.00. Klicka på länken nedan för ...

Read more

Mar

11

2025

Kommuniké från extra bolagsstämma i Hamlet BioPharma AB (publ) den 11 mars 2025

Hamlet Biopharma

|

Press releases

Vid extra bolagsstämma i Hamlet BioPharma AB (publ), org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) idag den 11 mars 2025 fattades bland ann...

Read more

Feb

21

2025

Hamlet BioPharma bjuder in till investerarmöte den 21 februari

Hamlet Biopharma

|

Press releases

Med anledning av  Pressmeddelanden och nyheter bjuder Hamlet BioPharma in till investerarmöte fredagen den 21 februari, 2025, klockan 12.00. Bolaget k...

Read more

Feb

20

2025

Kallelse till extra bolagsstämma i Hamlet BioPharma AB (publ)

Hamlet Biopharma

|

Press releases

Aktieägarna i Hamlet BioPharma AB (publ) (”Hamlet BioPharma” eller ”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma tisdagen den ...

Read more

Feb

20

2025

The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value ​​for both companies

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB (“Hamlet BioPharma” or the “Company”), an innovative pharmaceutical company that develops new therapies a...

Read more

Feb

19

2025

Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd

Hamlet Biopharma

|

Press releases

Hamlet BioPharma has appointed Elisabeth Parker, PhD to strengthen the business development expertise in the company. Dr. Parker has 25 years’ experi...

Read more

Feb

18

2025

Catharina Svanborg appointed as CEO and assumes the position immediately, board member Magnus Nylén acting Chairman

Hamlet Biopharma

|

Press releases

The Board of Hamlet BioPharma has today decided to appoint Catharina Svanborg as CEO. Catharina immediately assumes the CEO role and continues as a B...

Read more

Feb

13

2025

Q2 Interim Report October 2024 – December 2024

Hamlet Biopharma

|

Financial, Press releases

    ...

Read more

Feb

12

2025

Hamlet BioPharma bjuder in till pressträff den 13 februari med anledning av Q2 rapport

Hamlet Biopharma

|

Press releases

Med anledning av bolagets kvartalsrapport 2 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 13 februari, 2...

Read more

Feb

03

2025

Presentation den 6.2.25 på Vetenskapsrådets konferens kring Antibiotikaresistens

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB, det innovativa läkemedelsbolaget, som utvecklar nya terapier mot cancer och infektioner, meddelar två viktiga händelser. Den 6 f...

Read more

Jan

10

2025

Invitation to monthly digital events and presentations of quarterly reports

Hamlet Biopharma

|

Press releases

Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuab...

Read more

Dec

10

2024

Hamlet BioPharma presenterar vid Financial Stockholm-evenemanget den 11 december 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar att företaget kommer att delta och...

Read more

Dec

03

2024

Hamlet BioPharmas styrelse har idag beslutat om en riktad nyemission av B-aktier om drygt 26 miljoner kronor

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB (”Hamlet BioPharma” eller ”Bolaget”), ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddel...

Read more

Nov

28

2024

Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...

Read more

Nov

21

2024

Kommuniké från årsstämma i Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 21 november 2024 fattades de beslut som beskrivs ned...

Read more

Nov

19

2024

Hamlet BioPharma Participates in the BioStock Life Science Summit 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces its participation in the B...

Read more

Nov

15

2024

Q1 Interim Report July 2024 – September 2024

Hamlet Biopharma

|

Financial, Press releases

...

Read more

Nov

14

2024

Hamlet BioPharma bjuder in till pressträff den 18 november

Hamlet Biopharma

|

Press releases

Med anledning av bolagets kvartalsrapport 1 för 2024/2025, bjuder Hamlet BioPharma in till en livesänd digital pressträff måndagen den 18 november, 20...

Read more

Nov

04

2024

Two in-depth features about Hamlet BioPharma in the prestigious CEO world magazines and pulse 2.0 business news website

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, ticker HAMLET B, the innovative pharmaceutical company, which develops new therapies against cancer and infections, is pleased to in...

Read more

Oct

31

2024

Hamlet BioPharma publicerar årsredovisning 2023/2024

Hamlet Biopharma

|

Financial, Press releases

Årsredovisningen för Hamlet BioPharma AB avseende verksamhetsåret 2023/2024 är nu publicerad och bifogad i detta meddelande.   ...

Read more

Oct

24

2024

KALLELSE TILL ÅRSSTÄMMA I HAMLET BIOPHARMA AB

Hamlet Biopharma

|

Press releases

Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till årsstämma torsdagen den 21 november 2024 klockan 15:00 på High C...

Read more

Oct

08

2024

Immunterapi som behandling av återkommande urinvägsinfektioner – nu tre framgångsrika Fas II-studier i Hamlet BioPharma

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, det innovativa läkemedelsbolaget, som utvecklar nya terapier mot cancer och infektioner, meddelar att bolaget nu har tre framgångsri...

Read more